ARP Research and Funding Priorities
Funding Priorities:
Research Priorities:
Domestic:
-
Reducing racial/ethnic disparities in HIV testing, access, and utilization of treatment and services
-
Seek, test, treat, and retain—expanding HIV testing, linkage, and retention in care for hard-to-reach populations
-
Improving effectiveness of HIV therapy for substance abusers
-
Drug treatment as HIV prevention
-
Understanding transmission of HIV among drug users (both injection and non-injection) and their networks
-
Interventions for drug users involved in the criminal justice system
-
Research on substance abuse, risky decision-making, and impulsivity and HIV transmission among adolescents and adults
-
Strategies to coordinate and improve treatment and services for HIV, drug abuse, and co-occurring conditions (e.g., HCV)
-
Enhancing adherence to treatment for HIV and comorbid conditions
-
Drug abuse, HIV, and the brain
-
Genetics, epigenetics, proteomics, and systems biology studies in drug abusers and/or animal models of HIV
-
Research on structural interventions to prevent HIV/AIDS transmission and/or to enhance access/utilization of treatment and services
-
Training of new AIDS researchers
International:
-
Develop prevention strategies addressing non-injection drug use such as stimulants (e.g. methamphetamine, cocaine, crack) in vulnerable populations (e.g., MSM, young women) where prevalence is high (e.g., Latin America, Asia, Africa)
-
Develop prevention strategies addressing HIV/injection drug use epidemics in different geographic areas (Russia, China, SE Asia, India, Eastern/Central Europe)
-
Develop regional research networks
-
Develop new methods for gathering HIV epidemiological data and tracking HIV diffusion
-
Assess role of immigration and migration on HIV transmission
-
Drug treatment as HIV prevention, including development of long-acting, sustainable therapies
-
Assessment of HIV/AIDS treatment as HIV prevention
-
Implementation science research to guide scale-up of cost-effective interventions
-
HIV and co-infections (e.g., HCV, TB)
-
Support training new AIDS researchers